Aberrant cAMP metabolism in nf1 malignant peripheral nerve sheath tumor cells

Neurochemical Research

Volumn 36, Issue 9, 2011, Pages 1697-1705

  Dang, Ian ^a,b   De Vries, George H ^c,d  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CAMP; MPNST cell lines; Neurofibromatosis type I; Normal human Schwann cells; Prostaglandin metabolism; Schwann cells

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE TYPE III; ADENYLATE CYCLASE TYPE IV; ADENYLATE CYCLASE TYPE IX; CYCLIC AMP; PLATELET DERIVED GROWTH FACTOR BB; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; SCHWANN CELL; TUMOR CELL;

ADENYLATE CYCLASE; ADULT; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; DINOPROSTONE; HUMANS; ISOENZYMES; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; RECEPTORS, PROSTAGLANDIN; SCHWANN CELLS;

EID: 80755175881     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0433-2     Document Type: Article

References (40)

1. Friedman JM, Gutmann DH, MacCollin M, Ricardi VM (1999) Neurofibromatosis: Phenotype, natural history, and pathogenesis, 3rd edn. The Johns Hopkins University Press, Baltimore
2. Rosenbaum T, Petrie KM, Ratner N (1997) Neurofibromatosis type 1: Genetic and cellular mechanisms of peripheral nerve tumor formation. Neurosci 3:412-420
3. Morioka N, Tsuchida T, Etoh T, Ishibashi Y, Otsuka F (1990) A case of neurofibrosarcoma associated with neurofibromatosis: Light microscopic, ultrastructural, immunohistochemical and biochemical investigations. J Dermatol 17:312-316 (Pubitemid 20321661)
4. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet 39:311-314 (Pubitemid 34526349)
5. Sangueza OP, Requena L (1998) Neoplasms with neural differentiation: A review. Part II. Malignant neoplasms. Am J Dermapathol 20:89-102 (Pubitemid 28092715)
6. Ducatman BS, Scheithauer BW, Piepgrass DG, Reiman HM, Ilstrup DM (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006-2021 (Pubitemid 16113778)
7. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL (1998) Malignant peripheral nerve sheath tumor: Analysis of treatment outcome. Int J Radiat Oncol Phys 42:351-360 (Pubitemid 28502782)
8. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356:713-715
9. DeClue JE, Papageorge A, Diehl SR, Ratner N, Vass WC, Lowy DR (1992) Abnormal regulation of mammalian p21 ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 60:265-273
10. Feldkamp MM, Angelov L, Guha A (1999) Neurofibromatosis type 1 peripheral nerve tumors: Aberrant activation of the ras pathway. Surg Neurol 1:211-218 (Pubitemid 29095863)
11. Thomas SL, Deadwyler GD, Tang J, Stubbs EB Jr, Muir D, Hiatt KK, Clapp DW, De Vries GH (2006) Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells. Biochem Biophys Res Commun 348:971-980 (Pubitemid 44233511)
12. Li Y, Rao PK, Wen R, Song Y, Muir D, Wallace P, van Home SJ, Tennekoon GI, Kadesch T (2004) Notch and Schwann cell transformation. Oncogene 23:1146-1152 (Pubitemid 38269968)
13. Kim HA, Ratner N, Roberts TM, Stiles C (2001) Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin Dl. J Neurosci 21:1110-1116 (Pubitemid 32128756)
14. Tong J, Hannan F, Zhu Y, Bemards A, Zhong Y (2002) Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci 5:95-96 (Pubitemid 34121572)
15. Izawa I, Tamaki N, Saya H (1996) Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMPdependent protein kinase. FEBS Lett 382(1-2):53-59 (Pubitemid 26092233)
16. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK, Bernards A (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276(5313): 791-794 (Pubitemid 27199858)
17. Deadwyler GD, Dang I, Nelson J, Srikanth M, DeVries GH (2004) Prostaglandin E2 metabolism is activated in Schwann cell lines derived from human NF1 malignant peripheral nerve sheath tumors. Neuron Glia Biol 1(2):149-155
18. Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181-193
19. Ghosh N, Chaki R, Mandal V, Mandal SC (2010) COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62(2):233-244
20. Prasad KN, Cole WC, Yan XD, Nahreini P, Kumar B, Hanson A, Prasad JE (2003) Defects in cAMP-pathway may initiate carcinogenesis in dividing nerve cells: A review. Apoptosis 8(6): 579-586 (Pubitemid 37411742)
21. Badache A, DeVries GH (1998) Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB. J Cell Phys 177:334-342 (Pubitemid 28452834)
22. DeVries GH, Boullerne AI (2010) Glial cell lines: An overview. Neurochem Res 35:1978-2000
23. Casella GT, Wieser R, Bunge RP, Margitich IS, Katz J, Olson L, Wood PM (2000) Density dependent regulation of human Schwann cell proliferation. Glia 30:165-177 (Pubitemid 30199430)
24. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159 (Pubitemid 17064313)
25. Clive DR, Lopez TJ, DeVries GH (1998) Quantitation in PO mRNA by polymerase chain reaction in primary culture Schwann cells stimulated by axolemma-enriched fraction. J Neurosci Methods 81:24-34
26. Weinmaster G, Lemke G (1990) Cell-specific cyclic AMP-mediated induction of PDGF receptor. EMBO J 9:915-920
27. Menghi F, Jacques TS, Barenco M, Schwalbe EC, Clifford SC, Hubank M, Ham J (2011) Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development. Cancer Res [Epub ahead of print]
28. Coleman RA, Smith WL, Narumiya S (1994) International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229 (Pubitemid 24185151)
29. Sobue G, Shuman S, Pleasure D (1986) Schwann cell responses to cyclic AMP: Proliferation, changes in shape, and appearance of surface galactocerebroside. Brain Res 362:23-32 (Pubitemid 16185419)
30. Walikonis RS, Poduslo JF (1998) Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries. J Biol Chem 273: 9070-9077 (Pubitemid 28176195)
31. Fieber LA (1998) Ionic currents in normal and neurofibromatosis type 1-affected human Schwann cells: Induction of tumor cell K current in normal Schwann cells by cyclic AMP. J Neurosci Res 54(4):495-506 (Pubitemid 28507028)
32. Warrington NM, Gianino SM, Jackson E, Goldhoff P, Garbow JR, Piwnica-Worms D, Gutmann DH, Rubin JB (2010) Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. Cancer Res 70(14):5717-5727
33. Hegedus B, Dasgupta B, Shin JE, Emnett RJ, Hart-Mahon EK, Elghazi L, Bernal-Mizrachi E, Gutman DH (2007) Neurofibromatosis- 1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP-and Ras-dependent mechanisms. Cell Stem Cell 1(4):443457
34. Kim AK, DeClue JE, Ratner N (1997) cAMP-dependent protein kinase A is required for Schwann cell growth: Interactions between the cAMP and neuregulin/tyrosine kinase pathways. J Neurosci Res 49:236-247 (Pubitemid 27332722)
35. Marshall JS, Gomi K, Blennerhassett M, Bienenstock J (1999) Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 162:4271-4276 (Pubitemid 29314818)
36. Isaccson P (1976) Mast cells in benign nerve sheath tumours. J Pathol 119:193-196
37. Ricardi VM (1992) Neurofibromatosis. Phenotype, natural history of pathogenesis, 2nd edn. The John Hopkins University Press, Baltimore
38. Mrabet-Dahbi S, Metz M, Dudeck A, Zuberbier T, Maurer M (2009) Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol 18(5):437-444
39. Constable AL, Armati PJ, Toyka KV, Hartung HP (1994) Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 635:75-80
40. Feng L, Yunoue S, Tokuo H, Zhang D, Patrakitkomjorn S, Ichimura T, Saya H, Araki N (2004) PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type 1 tumor suppressor, neurofibomin. FEBS Lett 557(1-3):275-282 (Pubitemid 38115909)